Health-care companies fell after reports that UnitedHealth Group was under federal investigation. Shares of UnitedHealth plunged after reports the Department of Justice was investigating allegations ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

S&P 500 pharma stocks hold firm despite Trump’s drug pricing threat. Is Merck a put-selling opportunity amid headline noise?

ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Germany's Merck KGaA shares plunged after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange headwinds. In European morning trading shares were ...

FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for ...

Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...